Provera

Deponit Depo Provera Depo-provera Depo-Provera Deposition techniques... 

As of 1994, there were approximately 47 progestin-containing contraceptive dmg formulations sold in the United States for use as oral contraceptives (Table 3). In addition, there are three nonoral contraceptive formulations containing progestins ie, one injectable (Depo-Provera), one as an intrauterine device (lUD) (Progestasert), and one implantable (Norplant). Of the oral formulations, all but two also contain an estrogen component, ethynylestradiol. 

M. Dal Cin, S. Davalli, C. Marchioro, M. Passarini, O. Perini, S. Provera and A. Zaramella, Analytical Methods for Monitoring of Solid Phase Organic Synthesis, II Farmaco 57 497-510 2002. 

Premphase (Wyeth-Ayerst) Prempro (Wyeth-Ayerst) Provera (Pharmacia Upjohn)... 

DMPA 150 mg administered by deep intramuscular injection in the gluteal or deltoid muscle within 5 days of the onset of menstrual bleeding inhibits ovulation for more than 3 months, and the dose should be repeated every 12 weeks to ensure continuous contraception. A new formulation contains 104 mg of DMPA (Depo-SubQ Provera 104), which is injected subcutaneously into the thigh or abdomen. The manufacturer recommends excluding pregnancy in women more than 1 week late for repeat injection of the intramuscular formulation or 2 weeks late for repeat injection of the subcutaneous formulation. 

Carla Marchioro, Silvia Davalli, Stefano Provera, Markus Heller, Alfred Ross, and Hans Senn... 

Drug-drug interactions are often more problematic with carbamazepine than other mood stabilizers. Carbamazepine increases the activity of certain liver enzymes. Because these enzymes metabolize and eliminate medications and other substances introduced to the body, carbamazepine therapy can decrease the blood level and thereby reduce the effectiveness of itself (a phenomenon called autoinduction) and other medications that are metabolized by these enzymes. It is not unusual to find that the dose of carbamazepine must be increased after several weeks, because it has increased its own elimination. Other medications may likewise be less effective. Of particular concern are the oral contraceptives, Depo-Provera, and protease inhibitors used for the treatment of HI V+ patients. Oral contraceptives often require an increase in dose. 

Propafenone 58 Propeda 35 ProjDoxyphene 58, 74 Propranolol 58 Propulsid 24 Propylthiouracil 58 Proscar 35 Prostaphlin 54 Protamine 58 Protriptyline 58 Proventil 13 Provera 47 Pra/igil 49 Prozac 36... 

In 1992, the US FDA approved a long-acting contraceptive device containing synthetic progestin medroxyprogesterone acetate (MPA) hormones. Manufactured by Pfizer, Inc., it is sold under the trade name Depo-Provera . It is typically injected into a woman s buttocks or upper arm, and renders her temporarily sterile for up to 3 months. ... 

---